相关实验视频

Updated: Mar 14, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

胎盘重量可能通过调节脂质代谢来影响孕前或孕后风险:一种介导门德尔随机化分析门德尔随机化分析

Zhen Li¹, Liang Chen¹, Haoan Tang²

¹NHC Key Laboratory of Birth Defect for Research and Prevention, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, China.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

|March 12, 2026

概括

更高的胎盘体重 (PW) 与降低子宫前/子宫 (PE/E) 风险有关,可能由非常大的高密度脂蛋白 (HDL) 脂质介导. 这项研究探讨了胎盘大小和PE/E通过脂质代谢之间的因果关系.

科学领域:

产科和妇科产科和妇科
代谢障碍代谢障碍代谢障碍
遗传学遗传学是一个

背景情况:

孕前/孕后 (PE/E) 是孕产妇和产周死亡的主要原因之一.
在PE/E中异常的脂质谱是常见的,但胎盘生长和通过脂质代谢的PE/E风险之间的因果关系尚不清楚.

研究的目的:

调查胎盘体重 (PW) 对PE/E风险的因果关系.
探索脂质代谢作为PW-PE/E关系中介者的作用.

主要方法:

使用PW,代谢生物标志物 (NMR) 和PE/E的GWAS数据,采用了双样本的门德尔随机化 (MR).
分析包括PW → PE/E,PW →生物标志物和生物标志物 → PE/E,并对多次测试进行FDR校正.
调解分析使用双阶段MR和多变量MR (MVMR) 来评估间接和直接影响.

主要成果:

基因预测较高的PW与PE/E风险显著降低相关 (OR = 0.52,p = 0.013).
PW与特定的脂质生物标记物有关,特别是非常大的高密度脂蛋白 (HDL) 成分.
调解分析表明,通过非常大的HDL脂质 (例如,总脂质~10.4%) 进行部分调解.

结论:

研究结果支持PW较高和PE/E风险降低之间的保护性关联.
非常大的HDL脂质通路可能部分介导这种保护作用.
结果提供了与调解一致的证据,承认MR假设和潜在的重叠途径.

关键词:

胎盘重量胎盘重量埃克拉姆普西亚 (eclampsia) 是一种对身体的影响.脂质新陈代谢脂质新陈代谢门德尔的随机化是门德尔的随机化孕前症是什么意思

更多相关视频

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

相关概念视频

Regression Toward the Mean

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

Overview of Lipid Metabolism

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...